top of page
Ph.D. (Eng.), MBA
Founder & CEO
Kenta is a master of technical and tactical maneuvers, continuously demonstrating his exceptional skills in the cutting-edge field of peripheral stent development. He is not only a technical manager but a strategic and connected visionary, an indispensable member of this team. With over 10 years of research and development experience in leading research institutes and medical device manufacturers, Kenta's unwavering dedication to innovation and progress has earned him great respect and influence in the team.
Ph.D. (Eng.), MBA
Founder & COO
As an engineer, Shunto has led multiple medical device collaborations for 10 years, utilizing his expertise in thin film engineering and project management skills. His skill set is not only highly advanced in engineering, but he is also a very cooperative key player for managing team members, acting as a source of unification for various physicians, researchers, and engineers. With experience working for three medical device manufacturers, he is a key person in maximizing project success rates for this team.
Chief Medical Officer
Yukihisa, an Associate Professor in the Department of Diagnostic Radiology at Tokai University, brings a wealth of experience as an IR specialist to the table. With medical device development experience at Stanford University School of Medicine and unparalleled expertise in animal experiments, he is a uniquely qualified individual. His pivotal role in this project is the overall supervision of non-clinical and clinical trials, ensuring the success of this cutting-edge medical venture.
Yoko is an Assistant Professor in the Department of Diagnostic Radiology at Saitama Medical University International Medical Hospital, where she specializes in diagnostic and interventional radiology. The focus of her research is the biological response of intravascular devices, and within the scope of this project, she has taken charge of not only designing the user interface but also devising non-clinical trial protocols and performing histopathological analyses of stents. She is a key contributor to this cutting-edge research endeavor.
Shunsuke is an Assistant Professor in the Department of Diagnostic Radiology at Tokai University, where he brings his extensive experience as an IR specialist to the field. He has successfully performed many endovascular treatments for occlusive arterial disease, as well as embolization and endovascular repair for TAA and AAA cases. With an impressive background in animal studies involving pigs and rabbits, he is highly skilled in performing endovascular therapy on animals. Currently, he is leading the stent design in a new stent development project and employs his skills in drawing and finite element analysis to enhance the design process.
Fuyuaki is an expert on the polymer science, completing the doctoral program at Keio University. After working at a major manufacturing company, where he led several projects on the product-component development and the manufacturing processes, he has joined Global Vascular. Fuyuaki brings his scientific knowledge and the engineering experience to this team, and accelerates the development of the the devices.
M.D., Ph.D. (Dr. Eng.)
Chief Medical Director
Developer of F-DLC, an anti-thrombogenic material that is the fundamental technology for Biozone Coating. In clinical medicine, a specialist in radiological diagnostic science and image-guided treatments (IR and catheter treatments), with over 25 years of clinical experience. Currently holding concurrent positions as a Professor in the School of Medicine at Tokai University, Visiting Professor at the Center for Clinical Research Promotion in the School of Medicine at Keio University, and Visiting Professor at the Massachusetts Institute of Technology (MIT) and Harvard Medical School. Read more
Elazer R. Edelman
M.D., Ph.D., F.A.C.C.
Edelman is the Edward J. Poitras Professor in Medical Engineering and Science at MIT, Professor of Medicine at Harvard Medical School, and Senior Attending Physician in the coronary care unit at the Brigham and Women’s Hospital in Boston. Edelman advocates for multidisciplinary research and combines teams of clinicians, engineers, and scientists to create effective solutions for medical problems. His work has contributed significantly to the development and optimization of coronary stents, including bare-metal and drug-eluting stents. In this project, he is actively serving as an advisory board member.
bottom of page